Research & Clinical Trials

As the only national nonprofit advocacy organization focused on hereditary breast and ovarian cancer, FORCE has a strong commitment to promoting research.

Research & Clinical Trials > Clinical Trials & Research > PARP Inhibitor Breast Cancer Trials By State

| More

Research & Clinical Trials
Toggle Menu

PARP Inhibitor Breast Cancer Trials By State

PARP Inhibitor Breast Cancer Clinical Trials Listed by State

The below studies are PARP Inhibitor studies that are currently enrolling patients with breast cancer listed by state. For more details on an individual study, please contact the study coordinator or visit clinicaltrials.gov.

Arizona

California

Colorado

District of Columbia

Florida

Georgia

NCT01042379: I-SPY 2 TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer

Illinois

Indiana

Kansas

Maryland

Massachusetts

Michigan

Minnesota

Nebraska

New Jersey

New Mexico

New York

North Carolina

Ohio

Oregon

Pennsylvania

Tennessee

Texas

Virginia

Washington

 


Page updated 01/10/12